For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Travere Therapeutics Inc (NASDAQ: TVTX) closed at $14.99 down -9.48% from its previous closing price of $16.56. In other words, the price has decreased by -$9.48 from its previous closing price. On the day, 2.86 million shares were traded. TVTX stock price reached its highest trading level at $16.01 during the session, while it also had its lowest trading level at $14.85.
Ratios:
For a deeper understanding of Travere Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.08. In the meantime, Its Debt-to-Equity ratio is 6.80 whereas as Long-Term Debt/Eq ratio is at 5.54.
On October 21, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $9 to $27.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 12 ’25 when ROTE WILLIAM E. sold 5,200 shares for $23.53 per share. The transaction valued at 122,356 led to the insider holds 98,519 shares of the business.
REED ELIZABETH E sold 8,000 shares of TVTX for $188,240 on Feb 12 ’25. The SVP, GC & CORPORATE SECRETARY now owns 89,482 shares after completing the transaction at $23.53 per share. On Feb 11 ’25, another insider, Calvin Sandra, who serves as the SVP, CHIEF ACCOUNTING OFFICER of the company, sold 54,244 shares for $25.00 each. As a result, the insider received 1,356,100 and left with 54,410 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1330687744 and an Enterprise Value of 1361092992. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.71 while its Price-to-Book (P/B) ratio in mrq is 22.19. Its current Enterprise Value per Revenue stands at 5.837 whereas that against EBITDA is -6.401.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.92, which has changed by 1.1537356 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is -26.64%, while the 200-Day Moving Average is calculated to be -4.68%.
Shares Statistics:
For the past three months, TVTX has traded an average of 1.69M shares per day and 1851550 over the past ten days. A total of 87.45M shares are outstanding, with a floating share count of 87.44M. Insiders hold about 1.50% of the company’s shares, while institutions hold 109.22% stake in the company. Shares short for TVTX as of 1741910400 were 11194840 with a Short Ratio of 6.64, compared to 1739491200 on 11301636. Therefore, it implies a Short% of Shares Outstanding of 11194840 and a Short% of Float of 12.7.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
